118 related articles for article (PubMed ID: 818611)
1. Hurler syndrome: alpha-L-iduronidase activity in leukocytes as a method for heterozygote detection.
Wappner RS; Brandt IK
Pediatr Res; 1976 Jun; 10(6):629-32. PubMed ID: 818611
[TBL] [Abstract][Full Text] [Related]
2. alpha-L-iduronidase activity in leukocytes: diagnosis of homozygotes and heterozygotes of the Hurler syndrome.
Omura K; Higami S; Tada K
Eur J Pediatr; 1976 May; 122(2):103-5. PubMed ID: 817912
[TBL] [Abstract][Full Text] [Related]
3. Detection of the carrier state of Hurler's syndrome by assay of alpha-L-iduronidase in leukocytes.
Dulaney JT; Milunsky A; Moser HW
Clin Chim Acta; 1976 Jun; 69(2):305-10. PubMed ID: 819189
[TBL] [Abstract][Full Text] [Related]
4. A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome.
Whitley CB; Gorlin RJ; Krivit W
Am J Med Genet; 1987 Sep; 28(1):233-43. PubMed ID: 3118714
[TBL] [Abstract][Full Text] [Related]
5. Simplied assay method of alpha-L-iduronidase activity in leukocytes for detection of Hurler syndrome and its carriers.
Momoi T; Sudo M; Tanioka KI; Kushida H
Clin Chim Acta; 1977 Dec; 81(3):311-3. PubMed ID: 411615
[No Abstract] [Full Text] [Related]
6. [Use of 4-methylumbelliferryl-alpha-L-iduronide and 4-trifluoromethylumbelliferryl-alpha-L-iduronide for detecting alpha-L-iduronidase deficiencies in human tissue and for rapid prenatal diagnosis of Hurler disease].
Tsvetkova IV; Karpova EA; Voznyĭ IaV; Zolotukhina TV; Biriukov VB; Semiachkina AN
Vopr Med Khim; 1991; 37(1):74-7. PubMed ID: 1907053
[TBL] [Abstract][Full Text] [Related]
7. The use of alpha-L-iduronidase activity determinations in leucocytes for the detection of Hurler and Scheie syndromes.
Liem KO; Hooghwinkel GJ
Clin Chim Acta; 1975 Apr; 60(2):259-62. PubMed ID: 805007
[No Abstract] [Full Text] [Related]
8. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
Sheth KJ; Good TA; Murphy JV
Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
[TBL] [Abstract][Full Text] [Related]
9. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
Mueller OT; Shows TB; Opitz JM
Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
[TBL] [Abstract][Full Text] [Related]
10. Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-L-iduronidase.
Mandelli J; Wajner A; Pires R; Giugliani R; Coelho JC
Clin Chim Acta; 2001 Oct; 312(1-2):81-6. PubMed ID: 11580912
[TBL] [Abstract][Full Text] [Related]
11. Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
Aldenhoven M; de Koning TJ; Verheijen FW; Prinsen BH; Wijburg FA; van der Ploeg AT; de Sain-van der Velden MG; Boelens J
Biol Blood Marrow Transplant; 2010 May; 16(5):701-4. PubMed ID: 20096360
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction.
Whitley CB; Ramsay NK; Kersey JH; Krivit W
Birth Defects Orig Artic Ser; 1986; 22(1):7-24. PubMed ID: 3083887
[No Abstract] [Full Text] [Related]
13. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots.
Campos D; Monaga M; González EC; Herrera D
Clin Chim Acta; 2014 Mar; 430():24-7. PubMed ID: 24389097
[TBL] [Abstract][Full Text] [Related]
14. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
Liebaers I; Neufeld E
Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
[TBL] [Abstract][Full Text] [Related]
15. Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte alpha-L-iduronidase.
Mandelli J; Wajner A; Pires RF; Giugliani R; Coelho JC
Arch Med Res; 2002; 33(1):20-4. PubMed ID: 11825626
[TBL] [Abstract][Full Text] [Related]
16. Leucocyte values of alpha-L-iduronidase activity in mucopolysaccharidosis I.
Kelly TE; Taylor HA
J Med Genet; 1976 Apr; 13(2):149-51. PubMed ID: 819651
[TBL] [Abstract][Full Text] [Related]
17. Mucopolysaccharidosis type I: clinical and biochemical study.
Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
[TBL] [Abstract][Full Text] [Related]
18. The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features.
Stevenson RE; Howell RR; McKusick VA; Suskind R; Hanson JW; Elliott DE; Neufeld EF
Pediatrics; 1976 Jan; 57(1):111-22. PubMed ID: 813180
[TBL] [Abstract][Full Text] [Related]
19. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
[TBL] [Abstract][Full Text] [Related]
20. Optimization of enzymatic diagnosis for mucopolysaccharidosis I in dried blood spots on filter paper.
Campos D; Monaga M; González EC; Herrera D; de la Peña D
Clin Biochem; 2013 Jun; 46(9):805-9. PubMed ID: 23524317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
